Literature DB >> 28818009

Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.

Shannon G Gibson1, Renata E Axler2, Trudo Lemmens1.   

Abstract

A key issue impacting public trust in biobanks is how these resources are utilized, including who is given access to biobank data and samples. To assess the conditions under which researchers are given access to Canadian biobanks, we reviewed websites and contacted Canadian biobanks to determine the availability of information on access policies and procedures; research resulting from access biobank data and samples; and conditions on private industry access to biobanks. We also conducted expert interviews with key Canadian stakeholders ( n = 11) to obtain their perspectives on biobank transparency and access policies. Among 21 Canadian biobanks, there was wide variation in the access information made publicly available, and the majority of these allowed access by industry applicants. Biobanks should be governed by the principles of transparency, accountability, and accessibility, and attention must be given to the conditions around the commercialization of biobank-based research.

Keywords:  access policies; biobanks; commercialization; industry access; transparency

Mesh:

Year:  2017        PMID: 28818009     DOI: 10.1177/1556264617723137

Source DB:  PubMed          Journal:  J Empir Res Hum Res Ethics        ISSN: 1556-2646            Impact factor:   1.742


  1 in total

1.  Public trust and global biobank networks.

Authors:  Lisa Dive; Christine Critchley; Margaret Otlowski; Paul Mason; Miriam Wiersma; Edwina Light; Cameron Stewart; Ian Kerridge; Wendy Lipworth
Journal:  BMC Med Ethics       Date:  2020-08-15       Impact factor: 2.652

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.